The present invention relates generally to medical imaging, and specifically to visualizing an area of tissue in contact with an ablation electrode.
Arrhythmias are abnormal heart rhythms that are typically caused by a small area of cardiac tissue that produces irregular heartbeats. Cardiac ablation is a medical procedure that can be performed to treat an arrhythmia by destroying the area of the cardiac tissue causing the irregular heartbeats.
In some instances, cardiac ablation can be performed using a balloon catheter. A balloon catheter comprises an inflatable balloon at its distal end that can be inflated and deflated as necessary. The balloon typically comprises multiple electrodes configured to deliver ablation energy to tissue in contact with the electrodes. The balloon is typically deflated while the catheter is inserted into a body cavity (e.g., a heart) of a patient, inflated in order to perform the necessary procedure, and deflated again upon completing the procedure.
U.S. Pat. No. 6,514,249 to Maguire et al., describes a positioning system for orienting an ablation element within a pulmonary vein ostium. The system includes a position monitoring assembly that can be used to position a circumferential ablation member along a circumferential region of tissue at a location where a pulmonary vein extends from a left atrium.
U.S. Patent Application 2008/0275300 to Rothe et al., describes a complex shape steerable tissue visualization and manipulation catheter. The catheter includes a steering mechanism that can adjust a position of a visualization hood or membrane through which underlying tissue may be visualized.
The description above is presented as a general overview of related art in this field and should not be construed as an admission that any of the information it contains constitutes prior art against the present patent application.
There is provided, in accordance with an embodiment of the present invention, an apparatus including an invasive medical probe configured to be inserted into a body cavity and including a distal end having at least one elongated electrode disposed along the distal end, a position transducer associated with the medical probe, a memory configured to store a three-dimensional (3D) model of the body cavity, a display, and a processor configured to receive, from the position transducer, signals indicative of orientation and location coordinates of the distal end within the body cavity, to identify, based on the 3D model and the signals, a segment along a length of a given elongated electrode that is in contact with tissue at a site on an inner surface of the body cavity, while parts of the given elongated electrode other than the identified segment are not in contact with the inner surface of the body cavity, and to render to the display a graphical representation of the 3D model with a visual marker at a location on the 3D model corresponding to the site contacted by the segment of the given elongated electrode.
In some embodiments, the at least one elongated electrode is disposed longitudinally along the distal end of the medical probe.
In an additional embodiment, the invasive medical probe may also include an inflatable balloon that extends from a lumen in the distal end of the medical probe. In one embodiment, the at least one elongated electrode is disposed longitudinally on a surface of the balloon.
In another embodiment, the apparatus may also include an ablation module configured to deliver ablation energy to the at least one elongated electrode, thereby ablating the tissue that is in contact with the at least one electrode. In one embodiment, the visual marker corresponds to the site ablated by the segment of the given elongated electrode.
In a supplemental embodiment, processor can be configured, to receive, prior to receiving the signals, 3D model data for the body cavity, and to generate, using the 3D model data, the 3D model. In some embodiments, wherein the 3D model data can be selected from a list consisting of anatomical mapping data, computed tomography data, magnetic resonance imaging data and ultrasound data.
In a further embodiment, the processor can be configured to determine, based on the 3D model and the signals, an engagement contour of the segment along the length of the given elongated electrode that is in contact with the tissue, and wherein the processor is configured to render the visual marker at a location on the 3D model by presenting, at the location on the 3D model, a visual marker contour corresponding to the engagement contour.
There is also provided, in accordance with an embodiment of the present invention, a method including generating a three-dimensional (3D) model of a body cavity, receiving, from a position transducer associated with a medical probe configured to be inserted into the body cavity and including a distal end having at least one elongated electrode disposed along the distal end, signals indicative of orientation and location coordinates of the distal end within the body cavity, identifying, based on the 3D model and the signals, a segment along a length of a given elongated electrode that is in contact with tissue at a site on an inner surface of the body cavity, while parts of the given elongated electrode other than the identified segment are not in contact with the inner surface of the body cavity, and rendering to the display a graphical representation of the 3D model with a visual marker at a location on the 3D model corresponding to the site contacted by the segment of the given elongated electrode.
There is further provided, in accordance with an embodiment of the present invention, a computer software product operated in conjunction with a medical probe configured to be inserted into a body cavity and including a distal end having at least one elongated electrode disposed along the distal end, the product including a non-transitory computer-readable medium, in which program instructions are stored, which instructions, when read by a computer, cause the computer to generate a three-dimensional (3D) model of a body cavity, to receive, from a position transducer associated with the medical probe, signals indicative of orientation and location coordinates of the distal end within the body cavity, to identify, based on the 3D model and the signals, a segment along a length of a given elongated electrode that is in contact with tissue at a site on an inner surface of the body cavity, while parts of the given elongated electrode other than the identified segment are not in contact with the inner surface of the body cavity, and to render to the display a graphical representation of the 3D model with a visual marker at a location on the 3D model corresponding to the site contacted by the segment of the given elongated electrode.
The disclosure is herein described, by way of example only, with reference to the accompanying drawings, wherein:
Embodiments of the present invention describe a system and a method for presenting visual markers indicating areas of tissue being treated during a medical procedure such as cardiac ablation. As described hereinbelow, the system comprises an invasive medical probe configured to be inserted into a body cavity and comprising a distal end having at least one elongated electrode disposed along the distal end. For example, the medical probe may comprise an intracardiac catheter having a balloon affixed to the distal end, wherein the one or more elongated electrodes are mounted on an outer surface of the balloon
The system also comprises a position transducer associated with the medical probe. In some embodiments, as described hereinbelow, the position transducer may comprise a magnetic field sensor affixed to the distal end of the medical probe.
The system additionally comprises a display and a memory configured to store a three-dimensional (3D) model of the body cavity. In some embodiments, as described hereinbelow, the 3D model may be derived from an anatomical map, computerized tomography (CT) image data, magnetic resonance imaging (MRI) image data, or ultrasound image data.
The system further comprises a processor configured to receive, from the position transducer, signals indicative of orientation and location coordinates of the distal end within the body cavity, and to identify, based on the 3D model and the signals, a segment along a length of the elongated electrode that is in contact with tissue at a site on an inner surface of the body cavity, while parts of the elongated electrode other than the identified segment are not in contact with the inner surface of the body cavity. The processor is also configured to render to the display a graphical representation of the 3D model with a visual marker at a location on the 3D model corresponding to the site contacted by the segment of the elongated electrode.
By identifying respective segments of the elongated electrodes that are engaging tissue on the inner surface of the body cavity, systems implementing embodiments of the invention can aid a medical professional to accurately target areas of tissue for treatment. For example, if the elongated electrodes are configured to deliver ablation energy, systems implementing embodiments of the invention can accurately present the visual markers (e.g., ablation tags) that indicate locations in the tissue where the ablation energy is being delivered by the elongated electrodes during an ablation procedure.
Probe 22 comprises an insertion tube 30 and a handle 32 coupled to a proximal end of the insertion tube. By manipulating handle 32, a medical professional 34 can insert probe 22 into a body cavity in a patient 36. For example, medical professional 34 can insert probe 22 through the vascular system of patient 36 so that distal end 26 of probe 22 enters a chamber of heart 28 and engages endocardial tissue at a desired location or locations.
In a first embodiment of the configuration shown in
System 20 also comprises a position transducer 50 that is associated with medical probe 22, and a processor 52 in medical console 24. In embodiments described herein, position transducer 50 comprises a component of medical system 20 that generates and conveys position signals indicating a current position (i.e., location and orientation) of distal end 26, and processor 52 is configured to receive and process the conveyed position signals in order to compute, in coordinate system 38, orientation and location coordinates of distal end 26.
In the first embodiment of the configuration shown in
In this embodiment, system 20 measures the position of distal end 26 using magnetic-based sensors. Magnetic position tracking techniques are described, for example, in U.S. Pat. Nos. 5,391,199, 5,443,489, 6,788,967, 5,558,091, 6,172,499 and 6,177,792. The methods of location sensing described hereinabove are implemented in the above-mentioned CARTO® system and are described in detail in the patents cited above.
In addition to driver circuit 46 and processor 52, control console 24 also comprises a memory 54 and an input/output (I/O) communications interface 56. In embodiments described herein, memory 54 stores a 3D model 58 of heart 28 that processor 52 can generate based on 3D data such as anatomical mapping data received from a mapping catheter, computed tomography (CT) data, magnetic resonance imaging (MRI) data and ultrasound data. In some embodiments, memory 54 can also store a 3D model 60 of distal end 26, as described in the description referencing
In operation, I/O communications interface 56 enables control console 24 to receive signals from position transducer 50. Based on signals received from position transducer 50, processor 52 can process these signals in order to determine the position coordinates of distal end 26, typically comprising both location and orientation coordinates. As described in the description referencing
During the procedure, processor 52 can present, to medical professional 34, a graphical representation 62 of 3D model 58 on a display 64. In some embodiments, medical professional 34 can manipulate graphical representation 62 using one or more input devices 66. In alternative embodiments, display 64 may comprise a touchscreen that can be configured to accept inputs from medical professional 34, in addition to presenting graphical representation 62.
Processor 52 may comprise real-time noise reduction circuitry 68 typically configured as a field programmable gate array (FPGA), followed by an analog-to-digital (A/D) signal conversion integrated circuit 70. The processor can be programmed to perform one or more algorithms disclosed herein, each of the one or more algorithms comprising steps described hereinbelow. The processor uses circuitry 68 and circuit 70 as well as features of modules which are described in more detail below, in order to perform the one or more algorithms.
Memory 54 may comprise any suitable volatile and/or non-volatile memory, such as random access memory, a solid-state drive or a hard disk drive.
Medical probe 22 comprises a balloon 72 having multiple elongated electrodes 74 that can be used to ablate tissue in a body cavity such as heart 28. Balloon 72 and electrodes 74 are described in the description referencing
Control console 24 further comprises an irrigation module that controls the inflation of balloon 72 and an ablation module 78 that controls the delivery of ablation energy to elongated electrodes 74.
In a second embodiment of the configuration shown in
Control console 24 also comprises a current tracking module that, in conjunction with processor 52, determines position coordinates of distal end 26 inside heart 28 based on impedances and/or currents measured between adhesive skin patches 82 and electrodes 74. When using impedance-based location sensing to determine location coordinates of distal end 26 in coordinate system 38, position transducer 50 may comprise a selected electrode 74 operating with adhesive patches 82.
Impedance-based and current-based position tracking techniques are described, for example, in U.S. Pat. Nos. 5,983,126, 6,456,864 and 5,944,022. The methods of position sensing described hereinabove are implemented in the above-mentioned CARTO® system and are described in detail in the patents cited above.
In operation, irrigation module 76 can use irrigation fluid to inflate balloon 72, and can control the inflation of the balloon by controlling a flow rate of the irrigation fluid into the balloon. Balloon 72 is typically formed from bio-compatible material such as polyethylene terephthalate (PET), polyurethane, Nylon, or Pebax. In some embodiments, balloon 72 may comprise multiple small fenestrations (not shown) that allow the irrigation fluid to exit the balloon. These fenestrations are typically 0.025-0.500 millimeters in diameter.
Ablation module 78 is configured to monitor and control ablation parameters such as the level and the duration of ablation power (e.g., radio-frequency energy) conveyed to elongated electrodes 74 via I/O interface 56.
In the configuration shown in
Elongated electrodes 74 can be fabricated with the balloon and typically comprise gold overlaying the exterior wall of balloon 72. In embodiments of the present invention, the elongated electrodes have respective lengths 94 that are at least twice as long as their respective widths 96.
As shown in
In the configuration shown in
As shown in
In embodiments described hereinbelow, tissue 110 can be differentiated by appending a letter to the identifying numeral, so that the tissue comprises cardiac tissue 110A in heart 28, ostial tissue 110B in a pulmonary vein ostia 120, and intravenous tissue 110C in a pulmonary vein 122.
While the configuration of medical probe 22 presented in
To generate model 58, processor 52 receives three-dimensional data for tissue 110, and then segments the received three-dimensional data into a set of voxels 130, wherein each given voxel 130 corresponds to a respective set of 3D location coordinates in coordinate system 38. As described supra, examples of the 3D data include anatomical mapping data received from a mapping catheter, computed tomography (CT) data, magnetic resonance imaging (MRI) data and ultrasound data.
Each given record 162 comprises a set of 3D coordinates (i.e., in coordinate system 38) 164 for the corresponding voxel 150, and an electrode flag 166. In some embodiments, processor can set electrode flag 166 (e.g., to “True”) in a given record 162 if electrode definition 160 indicates that coordinates 164 in the given record correspond to the coordinates of a given elongated electrode 74.
When balloon 72 is inflated, the location coordinates that processor 52 computes for a given elongated electrode 74 (i.e., based on impedances and/or currents between adhesive skin patches 82 and the given elongated electrode) may comprise the location coordinates of a centroid of the given electrode. The centroid is herein assumed to be on the equator of balloon 72.
As described supra, balloon 72 has a generally spherical shape when inflated. Therefore, processor can use the location coordinates of the centroids of elongated electrodes to “model” balloon 72 so as to identify which voxels 150 correspond to the balloon, as described hereinbelow. In some embodiments, processor 52 can identify which voxels 150 correspond to elongated electrodes 74 based on the location coordinates of the centroids of the electrodes and electrode definition 160.
In an insertion step 172, medical professional 34 inserts distal end 26 of medical probe 22 into the body cavity. Upon inserting distal end into the body cavity, the medical professional can inflate balloon 72 using methods described hereinabove.
In a positioning step 174, the medical professional manipulates handle 32 so that one or more elongated electrodes 74 engage tissue (e.g., tissue 110) on an inner surface of the body cavity. For example, medical professional can position distal end 26 so that at least one elongated electrode 74 engages tissue 110A in heart 28.
In a receive step 176, processor 52 receives, from position transducer 50, signals indicative of an orientation 196 and location coordinates 198 of distal end 26, and in a computation step 178, the processor computes the orientation and the location coordinates (i.e., in coordinate system 38) of the distal end. In a first location computation embodiment, magnetic field sensor 108 conveys, to processor 52, electrical signals in response to the magnetic fields generated by the coils in field generators 48, and upon receiving the electrical signals, the processor can compute a position (i.e., location coordinates and an orientation) of the magnetic field sensor (and thereby the position of distal end 26) within the body cavity.
In a second location computation embodiment, processor 52 determines location coordinates of distal end 26 inside the body cavity based on impedances and/or currents measured between adhesive skin patches 82 and elongated electrodes 74. As described supra, elongated electrodes 74 are disposed longitudinally on the exterior surface of balloon 72. When balloon 72 is inflated, processor 52 can compute (as described supra) the 3D location coordinates for each given elongated electrode 74 as a centroid of the given electrode. In some embodiments, processor 52 can compute an orientation of distal end 26 based on the 3D location coordinates of electrodes 74.
In a second model generation step 179, processor 52 generates model 60 for balloon 72. Since balloon 72 has a generally spherical shape when inflated and elongated electrodes 74 are disposed on the outer surface of the balloon, processor can compute a center of balloon 72 as an average of the location coordinates corresponding to the respective centroids of elongated electrodes 74, and then compute a radius of the balloon based on the computed center and the location coordinates of the electrodes. Using the computed radius and center, processor 52 can then compute sets of 3D location coordinates for balloon 72 in coordinate system 38, segment the computed sets of 3D location coordinates into a set of voxels 150, and store, to the respective balloon coordinate record 162 for each given voxel 150, the computed 3D location coordinates to coordinates 164.
As described supra, distal end comprises balloon 72 and elongated electrodes 74. Based on the location coordinates for the centroids of elongated electrodes 74 and the dimension information stored in electrode definition 160, processor 52 can compute sets of 3D location coordinates for the electrodes, and set the electrode flags in the balloon coordinate records whose coordinates 164 match any of the computed sets of 3D location coordinates for the electrodes. In other words, processor 52 can identify which voxels 150 correspond to the 3D location coordinates of the elongated electrodes.
While a given elongated electrode 74 engages intravenous tissue 110C (or any other tissue 110 in a body cavity in patient 36), a given segment 192 of the given elongated electrode engages (i.e., is in contact with) the intravenous tissue at a given engagement area 194 on the intravenous tissue, while parts of the given elongated electrode other than the identified segment are not in contact with the intravenous tissue. In an identification step 180, processor 52 identifies respective segments 192 of the elongated electrodes engaging engagement areas 194 on the intravenous tissue.
In one embodiment, processor 52 can detect engagement areas 194 based on models 58 and 60. In this embodiment, processor 52 can use a collision detection algorithm on coordinate sets 142 and 164 to identify which voxels 150 are within a minimum distance threshold to any voxel 130. The identified voxels correspond to the location coordinates for engagement areas 194.
In the examples shown in
In some embodiments, as described hereinbelow, medical professional can instruct ablation module 78 to deliver ablation energy to elongated electrodes 74, thereby ablating intravenous tissue at engagement areas 194. In these embodiments, a line 190 connecting all engagement areas 194 may also be referred to as ablation line 190.
While the examples in
Returning to the flow diagram, in a rendering step 182, processor 52 renders, to display 64, graphical representation 62 of 3D model 58, with visual markers at respective locations in the 3D model corresponding to the engagement areas on intravenous tissue 110C. In some embodiments (as shown in
The examples shown in
Returning to the flow diagram, in a first decision step 184, if the engaged intravenous tissue comprises intravenous tissue 110C targeted for ablation, then in an ablation step 186, ablation module 78 conveys ablation energy to elongated electrodes 74, thereby ablating the intravenous tissue engaged by the elongated electrodes. In some embodiments, ablation module 78 can convey ablation energy to elongated electrodes 74 in response to input received from medical professional 34 (e.g., via input devices 66).
In some embodiments, processor 52 can render each given visual marker 210, 220 or 230 in response to ablation module 78 delivering ablation energy to elongated electrodes 74. In these embodiments, the visual markers comprise ablation tags that indicate ablation locations on intravenous tissue 110C.
In a second decision step 188, if the medical procedure is not complete, then the method continues with step 174. If the medical procedure is complete, then the method ends.
Returning to step 184, if the engaged intravenous tissue does not comprise intravenous tissue 110C targeted for ablation, then the method continues with step 188.
It will be appreciated that the embodiments described above are cited by way of example, and that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not disclosed in the prior art.
This application claims the benefits of priority under the Paris Convention as well as 35 USC § 119 from earlier filed U.S. Provisional Patent Application Ser. No. 62/934,331 filed on Nov. 12, 2019, titled “Accurate Positioning and Shape Visualization of Balloon Catheter Ablation Tags” which is hereby incorporated by reference as if set forth verbatim.
Number | Name | Date | Kind |
---|---|---|---|
D123782 | Paul | Dec 1940 | S |
3316896 | Louis | May 1967 | A |
4276874 | Wolvek et al. | Jul 1981 | A |
4587975 | Salo et al. | May 1986 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4805621 | Heinze et al. | Feb 1989 | A |
5178957 | Kolpe et al. | Jan 1993 | A |
5391199 | Ben-Haim | Feb 1995 | A |
5429617 | Hammersmark et al. | Jul 1995 | A |
5443489 | Ben-Haim | Aug 1995 | A |
5558091 | Acker et al. | Sep 1996 | A |
5582609 | Swanson et al. | Dec 1996 | A |
5584830 | Ladd et al. | Dec 1996 | A |
5702386 | Stern et al. | Dec 1997 | A |
5718241 | Ben-Haim et al. | Feb 1998 | A |
5797903 | Swanson et al. | Aug 1998 | A |
5860974 | Abele | Jan 1999 | A |
5944022 | Nardella et al. | Aug 1999 | A |
5971983 | Lesh | Oct 1999 | A |
5983126 | Wittkampf | Nov 1999 | A |
6012457 | Lesh | Jan 2000 | A |
6024740 | Lesh et al. | Feb 2000 | A |
6042580 | Simpson | Mar 2000 | A |
6123718 | Tu et al. | Sep 2000 | A |
6164283 | Lesh | Dec 2000 | A |
6171275 | Webster, Jr. | Jan 2001 | B1 |
6172499 | Ashe | Jan 2001 | B1 |
6176832 | Habu et al. | Jan 2001 | B1 |
6177792 | Govari et al. | Jan 2001 | B1 |
6198974 | Webster, Jr. | Mar 2001 | B1 |
6226542 | Reisfeld | May 2001 | B1 |
6301496 | Reisfeld | Oct 2001 | B1 |
6322558 | Taylor et al. | Nov 2001 | B1 |
6380957 | Banning | Apr 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
D462389 | Provence et al. | Sep 2002 | S |
6456864 | Swanson et al. | Sep 2002 | B1 |
6471693 | Carroll et al. | Oct 2002 | B1 |
6514249 | Maguire et al. | Feb 2003 | B1 |
6522930 | Schaer et al. | Feb 2003 | B1 |
6656174 | Hegde et al. | Dec 2003 | B1 |
6788967 | Ben-Haim et al. | Sep 2004 | B2 |
6814733 | Schwartz et al. | Nov 2004 | B2 |
6893433 | Lentz | May 2005 | B2 |
6986744 | Krivitski | Jan 2006 | B1 |
6987995 | Drysen | Jan 2006 | B2 |
6997924 | Schwartz et al. | Feb 2006 | B2 |
7142903 | Rodriguez et al. | Nov 2006 | B2 |
7156816 | Schwartz et al. | Jan 2007 | B2 |
7274957 | Drysen | Sep 2007 | B2 |
7340307 | Maguire et al. | Mar 2008 | B2 |
7377906 | Selkee | May 2008 | B2 |
7442190 | Abbound et al. | Oct 2008 | B2 |
7536218 | Govari et al. | May 2009 | B2 |
7591799 | Selkee | Sep 2009 | B2 |
7593760 | Rodriguez et al. | Sep 2009 | B2 |
7720517 | Drysen | May 2010 | B2 |
7756576 | Levin | Jul 2010 | B2 |
7842031 | Abboud et al. | Nov 2010 | B2 |
7853302 | Rodriguez et al. | Dec 2010 | B2 |
8000765 | Rodriguez et al. | Aug 2011 | B2 |
8021327 | Selkee | Sep 2011 | B2 |
8048032 | Root et al. | Nov 2011 | B2 |
8231617 | Satake | Jul 2012 | B2 |
8267932 | Baxter et al. | Sep 2012 | B2 |
8275440 | Rodriguez et al. | Sep 2012 | B2 |
8348888 | Selkee | Jan 2013 | B2 |
8357152 | Govari et al. | Jan 2013 | B2 |
D682289 | Dijulio et al. | May 2013 | S |
D682291 | Baek et al. | May 2013 | S |
D690318 | Kluttz et al. | Sep 2013 | S |
D694652 | Tompkin | Dec 2013 | S |
8641709 | Sauvageau et al. | Feb 2014 | B2 |
8721590 | Seward et al. | May 2014 | B2 |
8777161 | Pollock et al. | Jul 2014 | B2 |
D716340 | Bresin et al. | Oct 2014 | S |
8852181 | Malecki et al. | Oct 2014 | B2 |
D720766 | Mandal et al. | Jan 2015 | S |
D721379 | Moon et al. | Jan 2015 | S |
D724618 | Shin | Mar 2015 | S |
8998893 | Avitall | Apr 2015 | B2 |
D729263 | Ahn et al. | May 2015 | S |
9089350 | Willard | Jul 2015 | B2 |
D736780 | Wang | Aug 2015 | S |
9126023 | Sahatjian et al. | Sep 2015 | B1 |
D740308 | Kim et al. | Oct 2015 | S |
D743424 | Danielyan et al. | Nov 2015 | S |
D744000 | Villamor et al. | Nov 2015 | S |
9173758 | Brister et al. | Nov 2015 | B2 |
D747742 | Fan et al. | Jan 2016 | S |
D750644 | Bhutani et al. | Mar 2016 | S |
9283034 | Katoh et al. | Mar 2016 | B2 |
9289141 | Lowery et al. | Mar 2016 | B2 |
D753690 | Vazquez et al. | Apr 2016 | S |
9320631 | Moore et al. | Apr 2016 | B2 |
9345540 | Mallin et al. | May 2016 | B2 |
D759673 | Looney et al. | Jun 2016 | S |
D759675 | Looney et al. | Jun 2016 | S |
D764500 | Wang | Aug 2016 | S |
D765709 | Gagnier | Sep 2016 | S |
D767616 | Jones et al. | Sep 2016 | S |
D768696 | Gagnier | Oct 2016 | S |
D783037 | Hariharan et al. | Apr 2017 | S |
9655677 | Salahieh et al. | May 2017 | B2 |
D791805 | Segars | Jul 2017 | S |
9795442 | Salahieh et al. | Oct 2017 | B2 |
9907610 | Beeckler et al. | Mar 2018 | B2 |
9956035 | Govari et al. | May 2018 | B2 |
10413185 | Boveja et al. | Sep 2019 | B1 |
D861717 | Brekke et al. | Oct 2019 | S |
10688278 | Beeckler et al. | Jun 2020 | B2 |
10751121 | Govari et al. | Aug 2020 | B2 |
20010031961 | Hooven | Oct 2001 | A1 |
20020002369 | Hood | Jan 2002 | A1 |
20020065455 | Ben-Haim et al. | May 2002 | A1 |
20020068931 | Wong et al. | Jun 2002 | A1 |
20020077627 | Johnson et al. | Jun 2002 | A1 |
20020160134 | Ogushi et al. | Oct 2002 | A1 |
20030018327 | Truckai et al. | Jan 2003 | A1 |
20030028183 | Sanchez et al. | Feb 2003 | A1 |
20030050637 | Maguire et al. | Mar 2003 | A1 |
20030060820 | Maguire et al. | Mar 2003 | A1 |
20030144658 | Schwartz et al. | Jul 2003 | A1 |
20040122445 | Butler et al. | Jun 2004 | A1 |
20040147920 | Keidar | Jul 2004 | A1 |
20040225285 | Gibson | Nov 2004 | A1 |
20050070887 | Taimisto et al. | Mar 2005 | A1 |
20050119686 | Clubb | Jun 2005 | A1 |
20060013595 | Trezza et al. | Jan 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060135953 | Kania et al. | Jun 2006 | A1 |
20070071792 | Varner et al. | Mar 2007 | A1 |
20070080322 | Walba | Apr 2007 | A1 |
20070083194 | Kunis et al. | Apr 2007 | A1 |
20070287994 | Patel | Dec 2007 | A1 |
20080009700 | Dumoulin | Jan 2008 | A1 |
20080018891 | Hell et al. | Jan 2008 | A1 |
20080021313 | Eidenschink et al. | Jan 2008 | A1 |
20080051707 | Phan et al. | Feb 2008 | A1 |
20080140072 | Stangenes et al. | Jun 2008 | A1 |
20080183132 | Davies et al. | Jul 2008 | A1 |
20080188912 | Stone et al. | Aug 2008 | A1 |
20080202637 | Hector et al. | Aug 2008 | A1 |
20080208186 | Slater | Aug 2008 | A1 |
20080249463 | Pappone et al. | Oct 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20080275300 | Rothe et al. | Nov 2008 | A1 |
20080281312 | Werneth et al. | Nov 2008 | A1 |
20090163890 | Clifford et al. | Jun 2009 | A1 |
20090182318 | Abboud et al. | Jul 2009 | A1 |
20090270850 | Zhou et al. | Oct 2009 | A1 |
20100069836 | Satake | Mar 2010 | A1 |
20100114269 | Wittenberger et al. | May 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20100256629 | Wylie et al. | Oct 2010 | A1 |
20100324552 | Kauphusman et al. | Dec 2010 | A1 |
20110118632 | Sinelnikov et al. | May 2011 | A1 |
20110130648 | Beeckler et al. | Jun 2011 | A1 |
20110282338 | Fojtik | Nov 2011 | A1 |
20110295248 | Wallace et al. | Dec 2011 | A1 |
20110301587 | Deem et al. | Dec 2011 | A1 |
20110313286 | Whayne et al. | Dec 2011 | A1 |
20120019107 | Gabl et al. | Jan 2012 | A1 |
20120029511 | Smith et al. | Feb 2012 | A1 |
20120065503 | Rogers et al. | Mar 2012 | A1 |
20120071870 | Salahieh et al. | Mar 2012 | A1 |
20120079427 | Carmichael et al. | Mar 2012 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120101538 | Ballakur et al. | Apr 2012 | A1 |
20120143177 | Avitall | Jun 2012 | A1 |
20120143293 | Mauch et al. | Jun 2012 | A1 |
20120191079 | Moll et al. | Jul 2012 | A1 |
20120209260 | Lambert et al. | Aug 2012 | A1 |
20130085360 | Grunewald | Apr 2013 | A1 |
20130090649 | Smith et al. | Apr 2013 | A1 |
20130109982 | Sato et al. | May 2013 | A1 |
20130116550 | Ishii et al. | May 2013 | A1 |
20130150693 | D'Angelo et al. | Jun 2013 | A1 |
20130165916 | Mathur et al. | Jun 2013 | A1 |
20130165941 | Murphy | Jun 2013 | A1 |
20130165990 | Mathur et al. | Jun 2013 | A1 |
20130169624 | Bourier et al. | Jul 2013 | A1 |
20130261692 | Cardinal et al. | Oct 2013 | A1 |
20130274562 | Ghaffari et al. | Oct 2013 | A1 |
20130274658 | Steinke et al. | Oct 2013 | A1 |
20130282084 | Mathur et al. | Oct 2013 | A1 |
20130318439 | Landis et al. | Nov 2013 | A1 |
20140012242 | Lee et al. | Jan 2014 | A1 |
20140018788 | Engelman et al. | Jan 2014 | A1 |
20140031813 | Tellio et al. | Jan 2014 | A1 |
20140058197 | Salahieh et al. | Feb 2014 | A1 |
20140121470 | Scharf et al. | May 2014 | A1 |
20140148805 | Stewart et al. | May 2014 | A1 |
20140227437 | Deboer et al. | Aug 2014 | A1 |
20140243821 | Salahieh et al. | Aug 2014 | A1 |
20140275993 | Ballakur | Sep 2014 | A1 |
20140276756 | Hill | Sep 2014 | A1 |
20140276811 | Koblish et al. | Sep 2014 | A1 |
20140288546 | Sherman et al. | Sep 2014 | A1 |
20140330266 | Thompson et al. | Nov 2014 | A1 |
20140357956 | Salahieh et al. | Dec 2014 | A1 |
20150005799 | Lindquist et al. | Jan 2015 | A1 |
20150025532 | Hanson et al. | Jan 2015 | A1 |
20150025533 | Groff et al. | Jan 2015 | A1 |
20150057655 | Osypka | Feb 2015 | A1 |
20150067512 | Roswell | Mar 2015 | A1 |
20150080883 | Haverkost et al. | Mar 2015 | A1 |
20150105774 | Lindquist et al. | Apr 2015 | A1 |
20150112256 | Byrne et al. | Apr 2015 | A1 |
20150112321 | Cadouri | Apr 2015 | A1 |
20150119875 | Fischell et al. | Apr 2015 | A1 |
20150141982 | Lee | May 2015 | A1 |
20150157382 | Avitall et al. | Jun 2015 | A1 |
20150216591 | Cao et al. | Aug 2015 | A1 |
20150216650 | Shaltis | Aug 2015 | A1 |
20150265329 | Lalonde et al. | Sep 2015 | A1 |
20150265339 | Lindquist et al. | Sep 2015 | A1 |
20150265812 | Lalonde | Sep 2015 | A1 |
20150272667 | Govari et al. | Oct 2015 | A1 |
20150327805 | Ben-Haim | Nov 2015 | A1 |
20150341752 | Flynn | Nov 2015 | A1 |
20160000499 | Lennox et al. | Jan 2016 | A1 |
20160051321 | Salahieh et al. | Feb 2016 | A1 |
20160085431 | Kim et al. | Mar 2016 | A1 |
20160106499 | Ogata et al. | Apr 2016 | A1 |
20160166306 | Pageard | Jun 2016 | A1 |
20160175041 | Govari et al. | Jun 2016 | A1 |
20160196635 | Cho et al. | Jul 2016 | A1 |
20160256305 | Longo et al. | Sep 2016 | A1 |
20160374748 | Salahieh et al. | Dec 2016 | A9 |
20170042614 | Salahieh et al. | Feb 2017 | A1 |
20170042615 | Salahieh et al. | Feb 2017 | A1 |
20170080192 | Giasolli et al. | Mar 2017 | A1 |
20170143359 | Nguyen et al. | May 2017 | A1 |
20170164464 | Weinkam et al. | Jun 2017 | A1 |
20170311829 | Beeckler et al. | Nov 2017 | A1 |
20170311893 | Beeckler et al. | Nov 2017 | A1 |
20170312022 | Beeckler et al. | Nov 2017 | A1 |
20170347896 | Keyes et al. | Dec 2017 | A1 |
20180064495 | Hareland | Mar 2018 | A1 |
20180074693 | Jones et al. | Mar 2018 | A1 |
20180110562 | Govari et al. | Apr 2018 | A1 |
20180125575 | Schwartz et al. | May 2018 | A1 |
20180256247 | Govari et al. | Sep 2018 | A1 |
20180280080 | Govari et al. | Oct 2018 | A1 |
20180333162 | Saab | Nov 2018 | A1 |
20180368927 | Lyons et al. | Dec 2018 | A1 |
20190059818 | Herrera et al. | Feb 2019 | A1 |
20190060622 | Beeckler | Feb 2019 | A1 |
20190143079 | Beeckler et al. | May 2019 | A1 |
20190175262 | Govari et al. | Jun 2019 | A1 |
20190175263 | Altmann et al. | Jun 2019 | A1 |
20190183567 | Govari et al. | Jun 2019 | A1 |
20190201669 | Govari et al. | Jul 2019 | A1 |
20190217065 | Govari et al. | Jul 2019 | A1 |
20190297441 | Dehe et al. | Sep 2019 | A1 |
20190298441 | Clark et al. | Oct 2019 | A1 |
20190365451 | Jung, Jr. | Dec 2019 | A1 |
20200001054 | Jimenez et al. | Jan 2020 | A1 |
20200015693 | Beeckler et al. | Jan 2020 | A1 |
20200085497 | Zhang et al. | Mar 2020 | A1 |
20200155226 | Valls et al. | May 2020 | A1 |
20210169567 | Govari et al. | Jun 2021 | A1 |
Number | Date | Country |
---|---|---|
101422637 | May 2009 | CN |
102271607 | Dec 2011 | CN |
102458566 | May 2012 | CN |
203539434 | Apr 2014 | CN |
104244856 | Dec 2014 | CN |
104546117 | Apr 2015 | CN |
105105844 | Dec 2015 | CN |
105473091 | Apr 2016 | CN |
105473093 | Apr 2016 | CN |
0779059 | Jun 1997 | EP |
1790304 | May 2007 | EP |
2749214 | Jul 2014 | EP |
2865350 | Apr 2015 | EP |
2875790 | May 2015 | EP |
3238646 | Nov 2017 | EP |
3238648 | Nov 2017 | EP |
3251622 | Dec 2017 | EP |
3300680 | Apr 2018 | EP |
3315087 | May 2018 | EP |
3332727 | Jun 2018 | EP |
3 372 276 | Sep 2018 | EP |
3 384 852 | Oct 2018 | EP |
3571983 | Nov 2019 | EP |
3586778 | Jan 2020 | EP |
3653153 | May 2020 | EP |
H06261951 | Sep 1994 | JP |
H1176233 | Mar 1999 | JP |
2000504242 | Apr 2000 | JP |
2005052424 | Mar 2005 | JP |
2010507404 | Mar 2010 | JP |
2012024156 | Feb 2012 | JP |
2013013726 | Jan 2013 | JP |
2013031655 | Feb 2013 | JP |
2013078587 | May 2013 | JP |
2013529109 | Jul 2013 | JP |
2014529419 | Nov 2014 | JP |
2015503365 | Feb 2015 | JP |
2015100706 | Jun 2015 | JP |
2015112113 | Jun 2015 | JP |
2015112114 | Jun 2015 | JP |
2015518776 | Jul 2015 | JP |
2016515442 | May 2016 | JP |
2016116863 | Jun 2016 | JP |
2019034119 | Mar 2019 | JP |
0056237 | Sep 2000 | WO |
02102231 | Dec 2002 | WO |
2005041748 | May 2005 | WO |
2008049087 | Apr 2008 | WO |
2011143468 | Nov 2011 | WO |
2013049601 | Apr 2013 | WO |
2013052919 | Apr 2013 | WO |
2013154776 | Oct 2013 | WO |
2014168987 | Oct 2014 | WO |
2015049784 | Apr 2015 | WO |
2016183337 | Nov 2016 | WO |
2016210437 | Dec 2016 | WO |
2017024306 | Feb 2017 | WO |
2017087549 | May 2017 | WO |
2018106569 | Jun 2018 | WO |
2018129133 | Jul 2018 | WO |
2019095020 | May 2019 | WO |
Entry |
---|
Extended European Search Report issued in European Patent Application No. 20 20 6844 dated Mar. 16, 2021. |
Angela O., “AF Symposium 2017: First-in-Man Study Shows Promising Results with a Multi-Electrode Radiofrequency Balloon for Paroxysmal AF Treatment,” Cardiac Rhythm News, Jan. 20, 2017, 2 Pages, [Retrieved on Dec. 16, 2020] Retrieved from URL: https://cardiacrhythmnews.com/fist-in-man-study-shows-promising-results-with-a-multi-electrode-radiofrequency-balloon-for-paroxysmal-af-treatment/. |
Casella M., et al., “Ablation Index as a Predictor of Long-Term Efficacy in Premature Ventricular Complex Ablation: A Regional Target Value Analysis,” Heart Rhythm Society, Jun. 2019, vol. 16, No. 6, pp. 888-895. |
Co-Pending U.S. Appl. No. 14/578,807, filed Dec. 22, 2014, 21 pages. |
Das M., et al., “Ablation Index, a Novel Marker of Ablation Lesion Quality: Prediction of Pulmonary Vein Reconnection at Repeat Electrophysiology Study and Regional Differences in Target Values,” Europace, 2017, Published Online May 31, 2016, vol. 19, pp. 775-783. |
Dorobantu M., et al., “Oral Anticoagulation During Atrial Fibrillation Ablation: Facts and Controversies,” Cor et Vasa, 2013, Accepted on Dec. 3, 2012, vol. 55, No. 2, pp. e101-e106, Retrieved from URL: https://www.sciencedirect.com/science/article/pii/S0010865012001415. |
Extended European Search Report for Application No. EP17168513.4 mailed Sep. 18, 2017, 11 pages. |
Extended European Search Report for European Application No. 15201723.2, mailed May 11, 2016, 07 Pages. |
Extended European Search Report for European Application No. 17168393.1 mailed Dec. 15, 2017, 12 Pages. |
Extended European Search Report for European Application No. 17168518.3, mailed Sep. 20, 2017, 9 Pages. |
Extended European Search Report for European Application No. 17173893.3, mailed Nov. 6, 2017, 8 Pages. |
Extended European Search Report for European Application No. 17201434.2, mailed Feb. 1, 2018, 10 Pages. |
Extended European Search Report for European Application No. 17205876.0, mailed Jun. 1, 2018, 13 Pages. |
Extended European Search Report for European Application No. 19177365.4, mailed Nov. 8, 2019, 07 Pages. |
Extended European Search Report for European Application No. 19183327.6, mailed Nov. 21, 2019, 8 Pages. |
Extended European Search Report for European Application No. 20153872.5, mailed May 7, 2020, 9 Pages. |
Extended European Search Report for European Application No. 20195648.9, mailed Feb. 12, 2021, 8 Pages. |
Fornell D., “Multi-Electrode RF Balloon Efficient for Acute Pulmonary Vein Isolation,” Diagnostic and Interventional Cardiology, May 17, 2017, 3 Pages, [Retrieved on Dec. 16, 2020] Retrieved from URL: www.dicardiology.com/article/multi-electrode-rf-balloon-efficient-acute-pulmonary-vein-isolation. |
Haines D.E., et al., “The Promise of Pulsed Field Ablation,” Dec. 2019, vol. 19, No. 12, 10 pages. |
Honarbakhsh S., et al., “Radiofrequency Balloon Catheter Ablation for Paroxysmal Atrial Fibrillation, Radiance Study—a UK experience,” EP Europace, Oct. 2017, vol. 19, No. 1, p. i21, 3 Pages. |
International Search Report and Written Opinion for International Application No. PCT/IB2019/052313, mailed Jul. 22, 2019, 8 Pages. |
International Search Report and Written Opinion for International Application No. PCT/IB2019/056381, mailed Dec. 17, 2019, 10 pages. |
International Search Report and Written Opinion for International Application No. PCT/IB2019/057743, mailed Dec. 6, 2019, 16 Pages. |
International Search Report and Written Opinion issued in corresponding International Application No. PCT/IB2019/057742, dated Nov. 28, 2019, 18 Pages. |
Nagashima K., et al., “Hot Balloon Versus Cryoballoon Ablation for Atrial Fibrillation,” Circulation: Arrhythmia and Electrophysiology, May 2018, vol. 11, No. 5, e005861, 9 Pages. |
Napoli N., et al., “For Atrial Fibrillation Ablation, Newer Anticoagulant Reduces Major Bleeds,” American College of Cardiology, Mar. 19, 2017, 4 Pages, [Retrieved on Jan. 21, 2022] Retrieved from URL: https://www.acc.org/about-acc/press-releases/2017/03/18/08/47/sun-1045am-for-atrial-fibrillation-ablation-newer-anticoagulant-reduces-major-bleeds. |
Okano T., et al., “Wire Perforation Causing Cardiopulmonary Arrest During Radiofrequency Hot Balloon Ablation for Pulmonary Vein Isolation,” Journal of Cardiology Cases, Feb. 15, 2019, vol. 19, No. 5, pp. 169-172. |
Partial European Search Report for European Application No. 17168393.1 mailed Sep. 13, 2017, 13 Pages. |
Partial European Search Report for European Application No. 17205876.0, mailed Feb. 22, 2018, 10 Pages. |
Reddy V.Y., et al., “Balloon Catheter Ablation to Treat Paroxysmal Atrial Fibrillation: What is the Level of Pulmonary Venous Isolation?,” Heart Rhythm, Mar. 2008, vol. 5, No. 3, pp. 353-360, 3 Pages. |
Winkle R.A., et al., “Atrial Fibrillation Ablation Using Open-Irrigated Tip Radiofrequency: Experience with Intraprocedural Activated Clotting Times ≤ 210 Seconds,” Heart Rhythm, Jun. 2014, Epub Mar. 27, 2014, vol. 11, No. 6, pp. 963-968. |
Youtube:, “Intensity™ CX4 Professional E-Stim/ Ultrasound Combo,” Dec. 22, 2015, 1 Page, [Retrieved on Nov. 19, 2020], Retrieved from URL: https://www.youtube.com/watch?v=76s1QKMWJME]. |
Youtube: “New Interface TactiCath Contact Force Ablation Catheter,” Nov. 26, 2013, 1 Pages, [Retrieved on Nov. 19, 2020], Retrieved from URL: https: /Avww.youtube.com/watch?v=aYvYO8Hpylg]. |
Search Reported (English translation) dated Mar. 15, 2024, from corresponding Japanese Application No. 2020-187849. |
Notice of Reasons for Refusal (English translation) dated Mar. 19, 2024, from corresponding Japanese Application No. 2020-187849. |
Decision to Grant Patent (English translation) dated Jul. 2, 2024, from corresponding Japanese Application No. 2020-187849. |
Number | Date | Country | |
---|---|---|---|
20210137588 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
62934331 | Nov 2019 | US |